Literature DB >> 25608116

HJV and HFE Play Distinct Roles in Regulating Hepcidin.

Qian Wu1, Hao Wang, Peng An, Yunlong Tao, Jiali Deng, Zhuzhen Zhang, Yuanyuan Shen, Caiyong Chen, Junxia Min, Fudi Wang.   

Abstract

AIMS: Hereditary hemochromatosis (HH) is an iron overload disease that is caused by mutations in HFE, HJV, and several other genes. However, whether HFE-HH and HJV-HH share a common pathway via hepcidin regulation is currently unclear. Recently, some HH patients have been reported to carry concurrent mutations in both the HFE and HJV genes. To dissect the roles and molecular mechanisms of HFE and/or HJV in the pathogenesis of HH, we studied Hfe(-/-), Hjv(-/-), and Hfe(-/-)Hjv(-/-) double-knockout mouse models.
RESULTS: Hfe(-/-)Hjv(-/-) mice developed iron overload in multiple organs at levels comparable to Hjv(-/-) mice. After an acute delivery of iron, the expression of hepcidin (i.e., Hamp1 mRNA) was increased in the livers of wild-type and Hfe(-/-) mice, but not in either Hjv(-/-) or Hfe(-/-)Hjv(-/-) mice. Furthermore, iron-induced phosphorylation of Smad1/5/8 was not detected in the livers of Hjv(-/-) or Hfe(-/-)Hjv(-/-) mice. INNOVATION: We generated and phenotypically characterized Hfe(-/-)Hjv(-/-) double-knockout mice. In addition, because they faithfully phenocopy clinical HH patients, these mouse models are an invaluable tool for mechanistically dissecting how HFE and HJV regulate hepcidin expression.
CONCLUSIONS: Based on our results, we conclude that HFE may depend on HJV for transferrin-dependent hepcidin regulation. The presence of residual hepcidin in the absence of HFE suggests either the presence of an unknown regulator (e.g., TFR2) that is synergistic with HJV or that HJV is sufficient to maintain basal levels of hepcidin.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25608116      PMCID: PMC4410569          DOI: 10.1089/ars.2013.5819

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  40 in total

1.  Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice.

Authors:  G Nicolas; M Bennoun; I Devaux; C Beaumont; B Grandchamp; A Kahn; S Vaulont
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

2.  Ferroportin1 in hepatocytes and macrophages is required for the efficient mobilization of body iron stores in mice.

Authors:  Zhuzhen Zhang; Fan Zhang; Xin Guo; Peng An; Yunlong Tao; Fudi Wang
Journal:  Hepatology       Date:  2012-08-02       Impact factor: 17.425

3.  Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in mice.

Authors:  Elena Corradini; Delphine Meynard; Qifang Wu; Shan Chen; Paolo Ventura; Antonello Pietrangelo; Jodie L Babitt
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

Review 4.  Hepcidin and iron regulation, 10 years later.

Authors:  Tomas Ganz
Journal:  Blood       Date:  2011-02-23       Impact factor: 22.113

5.  Ferroportin1 deficiency in mouse macrophages impairs iron homeostasis and inflammatory responses.

Authors:  Zhuzhen Zhang; Fan Zhang; Peng An; Xin Guo; Yuanyuan Shen; Yunlong Tao; Qian Wu; Yuchao Zhang; Yu Yu; Bo Ning; Guangjun Nie; Mitchell D Knutson; Gregory J Anderson; Fudi Wang
Journal:  Blood       Date:  2011-06-24       Impact factor: 22.113

6.  Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice.

Authors:  Karin E Finberg; Rebecca L Whittlesey; Nancy C Andrews
Journal:  Blood       Date:  2011-02-25       Impact factor: 22.113

Review 7.  Importance of iron chelation in free radical-induced oxidative stress and human disease.

Authors:  Klaudia Jomova; Marian Valko
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

8.  LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity.

Authors:  A Krause; S Neitz; H J Mägert; A Schulz; W G Forssmann; P Schulz-Knappe; K Adermann
Journal:  FEBS Lett       Date:  2000-09-01       Impact factor: 4.124

9.  Hepcidin regulation by innate immune and infectious stimuli.

Authors:  Andrew E Armitage; Lucy A Eddowes; Uzi Gileadi; Suzanne Cole; Natasha Spottiswoode; Tharini Ashtalakshmi Selvakumar; Ling-Pei Ho; Alain R M Townsend; Hal Drakesmith
Journal:  Blood       Date:  2011-08-26       Impact factor: 22.113

10.  Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis.

Authors:  Antonella Roetto; George Papanikolaou; Marianna Politou; Federica Alberti; Domenico Girelli; John Christakis; Dimitris Loukopoulos; Clara Camaschella
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

View more
  10 in total

Review 1.  Liver iron sensing and body iron homeostasis.

Authors:  Chia-Yu Wang; Jodie L Babitt
Journal:  Blood       Date:  2018-11-06       Impact factor: 22.113

2.  Blood and iron.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2015-05       Impact factor: 4.599

Review 3.  Hepcidin: A Promising Therapeutic Target for Iron Disorders: A Systematic Review.

Authors:  Jing Liu; Bingbing Sun; Huijun Yin; Sijin Liu
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

4.  Minor variant of rs 16827043 in the iron regulator hemojuvelin gene (HJV) contributes to hypertension: The TAMRISK study.

Authors:  Seppo T Nikkari; Anni-Laura Visto; Kirsi M Määttä; Tarja A Kunnas
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

5.  Hemojuvelin regulates the innate immune response to peritoneal bacterial infection in mice.

Authors:  Qian Wu; Yuanyuan Shen; Yunlong Tao; Jiayu Wei; Hao Wang; Peng An; Zhuzhen Zhang; Hong Gao; Tianhua Zhou; Fudi Wang; Junxia Min
Journal:  Cell Discov       Date:  2017-08-15       Impact factor: 10.849

6.  Hemojuvelin is a novel suppressor for Duchenne muscular dystrophy and age-related muscle wasting.

Authors:  Peng Zhang; Jian He; Fei Wang; Jing Gong; Lu Wang; Qian Wu; Wenjiong Li; Hongju Liu; Jing Wang; Kunshan Zhang; Mao Li; Xusheng Huang; Chuanqiang Pu; Ying Li; Fengjie Jiang; Fudi Wang; Junxia Min; Xiaoping Chen
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-03-18       Impact factor: 12.910

7.  Repurposing ICG enables MR/PA imaging signal amplification and iron depletion for iron-overload disorders.

Authors:  Huirong Lin; Yu Zhou; Jiaming Wang; Huimeng Wang; Tianhong Yao; Hu Chen; Huili Zheng; Yang Zhang; En Ren; Lai Jiang; Chengchao Chu; Xiaoyuan Chen; Jingsong Mao; Fudi Wang; Gang Liu
Journal:  Sci Adv       Date:  2021-12-17       Impact factor: 14.136

8.  New Deferric Amine Compounds Efficiently Chelate Excess Iron to Treat Iron Overload Disorders and to Prevent Ferroptosis.

Authors:  Wenya Feng; Yuanjing Xiao; Chuanfang Zhao; Zhanming Zhang; Wei Liu; Juan Ma; Tomas Ganz; Junliang Zhang; Sijin Liu
Journal:  Adv Sci (Weinh)       Date:  2022-08-28       Impact factor: 17.521

9.  HFE inhibits type I IFNs signaling by targeting the SQSTM1-mediated MAVS autophagic degradation.

Authors:  Juan Liu; Xiaopeng Wu; Hailong Wang; Jiayu Wei; Qian Wu; Xingbo Wang; Yan Yan; Jun Cui; Junxia Min; Fudi Wang; Jiyong Zhou
Journal:  Autophagy       Date:  2020-08-18       Impact factor: 13.391

10.  Evidence That HFE H63D Variant Is a Potential Disease Modifier in Cluster Headache.

Authors:  Maria Papasavva; Michail Vikelis; Martha-Spyridoula Katsarou; Vasileios Siokas; Emmanouil Dermitzakis; Christoforos Papademetriou; Konstantinos Karakostis; George Lazopoulos; Efthimios Dardiotis; Nikolaos Drakoulis
Journal:  J Mol Neurosci       Date:  2021-09-27       Impact factor: 3.444

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.